Regenerex Pharma (RGPX) Research & Development (2018 - 2025)

Regenerex Pharma (RGPX) has 4 years of Research & Development data on file, last reported at $136432.0 in Q3 2025.

• Research & Development for Q3 2025 came in at $136432.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $798911.0 (changed N/A YoY), and the FY2025 annual result was $662479.0, down 72.4% from the prior year.
• Research & Development slipped to $136432.0 in Q3 2025 per RGPX's latest filing, from $645099.0 in the prior quarter.
• Over five years, Research & Development peaked at $2.4 million in Q3 2023 and troughed at $17380.0 in Q4 2024.
• A 3-year average of $799727.8 and a median of $390765.5 in 2025 frame the typical range for Research & Development.